相关实验视频

Updated: May 6, 2026

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

使用非传染性病毒复制物粒子生成的尼帕病毒衍生有缺陷的干扰颗粒赋予了与使用标准全长传染性病毒颗粒产生的保护效果相似的保护效果

Stephen R Welch¹, Jessica R Spengler¹, Sarah C Genzer¹

¹Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA.

Antiviral research

|December 24, 2025

概括

有缺陷的干扰颗粒 (DIPs) 提供了对抗尼帕病毒 (NiV) 感染的有希望的策略. 一个新的BSL-2系统可以安全,高效地生产NiV DIP,克服临床使用的障碍.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
医疗对策医学对策

背景情况:

缺陷干扰颗粒 (DIP) 是具有截断基因组的病毒样颗粒.
DIP显示出作为对抗病毒感染的医疗对策 (MCM) 的潜力.
之前的研究表明,尼帕病毒 (NiV) 衍生的DIPs可以降低子的NiV疾病严重程度.

研究的目的:

开发一种更安全,更容易获得的方法来生产NiV衍生DPI.
克服使用传染性NiV和高封闭设施 (BSL-4) 为DIP生成的局限性.
为了促进对NiV和相关的海尼帕病毒的DIP治疗方法的进步.

主要方法:

开发一种非传染性,BSL-2兼容的NiV复制系统.
使用改进的复制系统生成NiV DIP.
在体外测试DIP的抗病毒活性.
在叙利亚仓鼠模型中对DIP疗效的体内测试.

主要成果:

新的NiV复制系统成功地产生了DIP,而不需要感染性NiV或BSL-4制.
通过这种系统生产的DIP在体外显示出明显的NiV复制抑制.
这些DIP保持了对子NiV疾病的充分保护效果,减少了临床症状和死亡率.
新方法显著减少了DIP生产的监管和实际障碍.

结论:

一个改进的,非传染性的NiV复制系统可促进BSL-2兼容的DIP生成.
这种方法克服了NiV DIPs临床转化的主要障碍.
开发的DIP是对NiV有效的MCM,为临床评估铺平了道路.

关键词:

动物动物动物动物动物动物抗病毒剂是一种抗病毒剂.有缺陷的干扰病毒.疾病模型的疾病模型.黑尼帕病毒感染的感染梅索克里塞托斯 (Mesocricetus) 是一个巨大的行星.复制器 (Replicon) 是一个复制器.

更多相关视频

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...